Views

Daltons and grams: Measuring mass in biology

Molecular structure such as small molecules and proteins are typically measure in Daltons. Whereas larger structures are measure in grams. We thought it would be interesting to apply both scales across a range of biological entities, from a water molecule to blue whale.

Read More

Will climate change increase mutation and cancer risk?

Will climate change increase mutation and cancer risk?

Rising sea levels, extreme weather, and ecosystem disruption, are well known consequences of climate change, but emerging research also reveals a more intimate threat: climate change may be directly damaging our chromosomes and altering our genetic makeup. This hidden consequence could have profound implications for human health and evolution.

Read More

Can CAR-T cells succeed in solid cancers?

Can CAR-T cells succeed in solid cancers?

We explore the status of CAR T-cell therapy in the treatment of solid tumors, possible causes of failure, potential solutions, and the progress of CAR T-cell therapy for solid tumors and discuss the possible significance of CAR T-cell therapy for cancer treatment in the future.

Read More

iNKing out cancer: A better CAR-T cell?

iNKing out cancer: A better CAR-T cell?

CAR-T has been revolutionary, but as an autologous therapy, it is slow and costly. Allogeneic CAR-T cells, known as iNKTS, are now in development and may offer a rapid, cheaper (and perhaps more effective) off-the-shelf solution.

Read More

PROTACs: Degrading can be good

PROTACs: Degrading can be good

Targeted protein degradation (TPD) is an emerging technique used to study cellular processes and develop new therapies. Introduced in 1999, TPD works by breaking down specific proteins using either the proteasomal or lysosomal pathways. Most current TPD methods, such as PROTACs, molecular glues, Trim-Away, and SNIPERs, depend on the ubiquitin-proteasome system (UPS) and are primarily designed to target proteins inside cells.

Read More